Milestone Pharmaceuticals Inc (MIST) — Capital Reinvestment Ratio

Latest as of June 2021: 0.05x

Milestone Pharmaceuticals Inc (MIST) has a Capital Reinvestment Ratio of 0.05x as of June 2021, meaning it reinvests 0% of its operating cash flow ($1.01 Million) in capital expenditures ($46.00K). Check Milestone Pharmaceuticals Inc (MIST) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.05x

Capex / Operating Cash Flow

Operating Cash Flow

$1.01 Million

USD

Capital Expenditures

$46.00K

USD

Data as of

Jun 2021

Most recent filing

Annual Capital Reinvestment Ratio for Milestone Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Milestone Pharmaceuticals Inc from None to None. See MIST free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow